U.S. market Closed. Opens in 2 days 2 hours 39 minutes

RVPHW | Reviva Pharmaceuticals Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312020-02-292019-02-28
RevenueN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/A724.74KN/AN/A
Gross ProfitN/AN/AN/A-724.74KN/AN/A
Operating Expenses39.50T24.31M10.10M2.43M376.86K1.12M
Selling, General & Admin8.08T5.36M5.25M2.14M181.12K175.58K
Research & Development31.42T18.95M4.85M295.15K195.74K946.30K
Other Operating ExpensesN/AN/AN/AN/AN/A0
Operating Income-39.50T-24.31M-10.10M-2.43M-376.86K-1.12M
Other Expenses / Income39.50T-11.91K1.59M-1.35M-469.17K-557.67K
Before Tax Income-39.24M-24.32M-8.52M-3.78M-846.03K-1.68M
Income Tax Expenses-16.95B20.78K6.00K800.00800.00800.00
Net Income-39.26T-24.34M-8.52M-3.78M-846.83K-1.68M
Interest ExpensesN/A182.80K2.41K1.45M469.37KN/A
Basic Shares Outstanding23.80M19.52M14.79M3.06M2.77MN/A
Diluted Shares Outstanding23.80M19.52M14.79M3.06M2.77MN/A
EBITDA-39.50T-24.11M-10.10M-2.33M-376.01K-1.12M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-39.28T-24.14M-8.51M-2.33M-376.66K-1.68M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312020-02-292019-02-28
An error has occurred. This application may no longer respond until reloaded. Reload 🗙